Clinical trial
Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
NCT00608712 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
- Lead sponsor
- AstraZeneca
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2005
- Completion date
- August 31, 2006
- Enrollment
- 140 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative bariatric surgery